Search results
Showing 91 to 105 of 8183 results
NICE has published final draft guidance that does not recommend Enhertu (also called trastuzumab deruxtecan and made by Daiichi Sankyo) for treating advanced HER2-low breast cancer in adults.
We want you to tell us what matters to you, your organisation or your community.
Vitamin B12 deficiency in over 16s: diagnosis and management (NG239)
This guideline covers recognising, diagnosing and managing vitamin B12 deficiency in people aged 16 and over, including deficiency caused by autoimmune gastritis. It also covers monitoring for gastric cancer in people with autoimmune gastritis.
Digital technologies for managing non-specific low back pain: early value assessment (HTE16)
Early value assessment (EVA) guidance on digital technologies for managing non-specific low back pain in people 16 years and over....
View recommendations for HTE16Show all sections
A new treatment option given with chemotherapy is recommended for some types of advanced or recurrent womb cancer in final draft NICE guidance published today.
Admission rates due to heart failure in people with diabetes
Admission rates due to heart failure in people with diabetes Subject(s): Diabetes Date of publication: 01 August
We're excited that you're interested in joining a committee and helping us improve health and social care services. By joining, you'll have the...
All our committees include experienced professionals with knowledge of a particular topic within health or social care . Professional members also...
Find out more about being on a committee at NICE.
A public consultation on our new approach to prioritising guidance is now open
Running for 4 weeks, the consultation seeks your views about our plans to make topic selection and prioritisation more integrated, effective and timely.
Achieving and demonstrating compliance with NICE TA and HST guidance
The NHS and patients need evidence that commissioners are funding medicines and treatments approved through the NICE Technology Appraisal (TA) or...
Support for industry to engage with NICE during all stages of health technology development
Supporting the health and care system in improving productivity
Recovering core services and improving productivity is an immediate priority for the NHS. To help, we’ve put all our relevant guidance and recommendations supporting this work in one place.
PDAs help people decide on healthcare options. They provide evidence-based information on the options available, along with likely outcomes, benefits,
Our indicators measure outcomes that reflect quality of care. They also look at processes that are linked by evidence to improved outcomes. All our...